allogeneic cell therapy
-
Biologics
Bone Therapeutics’ allogeneic cell therapy product, ALLOB, meets primary endpoints in Phase IIa study in patients undergoing a lumbar spinal fusion procedure
June 13, 2019 / Source: Bone Therapeutics SA Regulated Information – Inside Information Treatment with ALLOB resulted in significant clinical and radiological improvementsTreatment with…
Read More » -
Extremities
TissueGene, Inc. Announces Special Protocol Assessment (SPA) Agreement with the Food and Drug Administration (FDA) for its Phase 3 Clinical Trial of Invossa™ for Patients Suffering from Osteoarthritis of the Knee
ROCKVILLE, Md., May 15, 2015 /PRNewswire/ — TissueGene, Inc. announced today that it has reached an agreement with the U.S. Food…
Read More » -
Recon
TissueGene, Inc. Presents Phase 2 Data for Its Novel Cell Therapy for the Treatment of Osteoarthritis of the Knee
ROCKVILLE, Md., May 11, 2015 /PRNewswire/ — TissueGene Inc. is pleased to announce that Dr. Moon Jong Noh, VP of Research…
Read More »